Eur J Pediatr Surg 2018; 28(05): 393-399
DOI: 10.1055/s-0037-1604116
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Atropine Treatment for Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis

Giuseppe Lauriti
1   Department of Pediatric Surgery, “Spirito Santo” Hospital and “G. d'Annunzio” University, Chieti-Pescara, Italy
2   Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada
,
Valentina Cascini
1   Department of Pediatric Surgery, “Spirito Santo” Hospital and “G. d'Annunzio” University, Chieti-Pescara, Italy
,
Pierluigi Lelli Chiesa
1   Department of Pediatric Surgery, “Spirito Santo” Hospital and “G. d'Annunzio” University, Chieti-Pescara, Italy
,
Agostino Pierro
2   Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada
,
Augusto Zani
2   Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

20 March 2017

28 May 2017

Publication Date:
12 July 2017 (online)

Abstract

Introduction Several authors have reported the use of atropine as an alternative treatment to pyloromyotomy in infants with hypertrophic pyloric stenosis (HPS). Our aims were to review the efficacy of atropine in treating HPS and to compare atropine therapy versus pyloromyotomy.

Materials and Methods Using a defined search strategy (PubMed, MEDLINE, OVID, Embase, Cochrane databases), two investigators independently identified studies reporting the use of atropine for HPS. Case reports and opinion articles were excluded. Outcome measures included success rate, side effects, and length of hospital stay. Maneuvers were compared using Fisher's exact test, and meta-analysis was conducted using RevMan 5.3. Data are expressed as mean ± standard deviation.

ResultsSystematic review: of 2,524 abstracts screened, 51 full-text articles were analyzed. There were no prospective or randomized studies. Twelve articles (508 infants) reported HPS resolution using atropine in 402 (79.1%) patients. Atropine side effects were documented in 38/251 (15.1%) infants and included tachycardia, increased transaminases, and flushed skin. Meta-analysis: five studies compared atropine treatment (293 infants) with pyloromyotomy (537 infants). Pyloromyotomy had higher success rate (100%) than atropine (80.8%; p < 0.01) and shorter hospital stay (5.6 ± 2.3 vs. 10.3 ± 3.8 days, respectively; p < 0.0001).

Conclusion Comparative but nonrandomized studies indicate that atropine is less effective than pyloromyotomy to treat infants with HPS. Currently, there is no evidence-based literature to support atropine treatment in these infants. To our knowledge, atropine should be reserved for patients unfit for general anesthesia or surgery.

 
  • References

  • 1 Puri P, Kutasy B, Lakshmanadass G. Hypertrophic pyloric stenosis. In: Puri P. , ed. Newborn Surgery, London: Hodder Arnold; 2011: 433-442
  • 2 Ramstedt C. Zur operation der angeborenen pylorus stenose. Med Klin 1912; 26: 1191-1192
  • 3 Tan KC, Bianchi A. Circumumbilical incision for pyloromyotomy. Br J Surg 1986; 73 (05) 399
  • 4 Alain JL, Grousseau D, Terrier G. Extra-mucosa pylorotomy by laparoscopy [in French]. Chir Pediatr 1990; 31 (4-5): 223-224
  • 5 Hall NJ, Pacilli M, Eaton S. , et al. Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial. Lancet 2009; 373 (9661): 390-398
  • 6 Oomen MWN, Hoekstra LT, Bakx R, Ubbink DT, Heij HA. Open versus laparoscopic pyloromyotomy for hypertrophic pyloric stenosis: a systematic review and meta-analysis focusing on major complications. Surg Endosc 2012; 26 (08) 2104-2110
  • 7 Jacoby NM. Pyloric stenosis: selective medical and surgical treatment. A survey of sixteen years' experience. Lancet 1962; 1 (7221): 119-121
  • 8 Corner BD. Hypertrophic pyloric stenosis in infancy treated with methyl scopolamine nitrate. Arch Dis Child 1955; 30 (152) 377-386
  • 9 Mellin GW, Santulli TV, Altman HS. Congenital pyloric stenosis: a controlled evaluation of medical treatment utilizing methyl-scopolamine-nitrate. J Pediatr 1965; 66: 649-657
  • 10 Day LR. Medical management of pyloric stenosis. JAMA 1969; 207 (05) 949-950
  • 11 Schärli A, Sieber WK, Kiesewetter WB. Hypertrophic pyloric stenosis at the Children's Hospital of Pittsburgh from 1912 to 1967. A critical review of current problems and complications. J Pediatr Surg 1969; 4 (01) 108-114
  • 12 Nagita A, Yamaguchi J, Amemoto K, Yoden A, Yamazaki T, Mino M. Management and ultrasonographic appearance of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate. J Pediatr Gastroenterol Nutr 1996; 23 (02) 172-177
  • 13 Yamataka A, Tsukada K, Yokoyama-Laws Y. , et al. Pyloromyotomy versus atropine sulfate for infantile hypertrophic pyloric stenosis. J Pediatr Surg 2000; 35 (02) 338-341
  • 14 Riccabona M, Weitzer C, Lindbichler F, Mayr J. Sonography and color Doppler sonography for monitoring conservatively treated infantile hypertrophic pyloric stenosis. J Ultrasound Med 2001; 20 (09) 997-1002
  • 15 Singh UK, Kumar R, Suman S. Successful management of infantile hypertrophic pyloric stenosis with atropine sulfate. Indian Pediatr 2001; 38 (10) 1099-1105
  • 16 Sretenović A, Smoljanić Z, Korać G, Sindjeć S, Lukac M, Krstić Z. Conservative treatment of hypertrophic pyloric stenosis in children [in Serbian]. Srp Arh Celok Lek 2004; 132 (Suppl. 01) 93-96
  • 17 Singh UK, Kumar R, Prasad R. Oral atropine sulfate for infantile hypertrophic pyloric stenosis. Indian Pediatr 2005; 42 (05) 473-476
  • 18 Kawahara H, Takama Y, Yoshida H. , et al. Medical treatment of infantile hypertrophic pyloric stenosis: should we always slice the “olive”?. J Pediatr Surg 2005; 40 (12) 1848-1851
  • 19 Meissner PE, Engelmann G, Troeger J, Linderkamp O, Nuetzenadel W. Conservative treatment of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate does not replace pyloromyotomy. Pediatr Surg Int 2006; 22 (12) 1021-1024
  • 20 Koike Y, Uchida K, Nakazawa M, Inoue M, Kusunoki M, Tsukamoto Y. Predictive factors of negative outcome in initial atropine therapy for infantile hypertrophic pyloric stenosis. Pediatr Int 2013; 55 (05) 619-623
  • 21 Lukac M, Antunovic SS, Vujovic D. , et al. Is abandonment of nonoperative management of hypertrophic pyloric stenosis warranted?. Eur J Pediatr Surg 2013; 23 (01) 80-84
  • 22 Takeuchi M, Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S. Pyloromyotomy versus i.v. atropine therapy for the treatment of infantile pyloric stenosis: nationwide hospital discharge database analysis. Pediatr Int 2013; 55 (04) 488-491
  • 23 Fan J, Shi Y, Cheng M, Zhu X, Wang D. Treating idiopathic hypertrophic pyloric stenosis with sequential therapy: a clinical study. J Paediatr Child Health 2016; 52 (07) 734-738
  • 24 Moher D, Liberati A, Tetzlaff J, Altman DG. ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
  • 25 PROSPERO International Prospective Register of Systematic Reviews. Available at: http://www.crd.york.ac.uk/prospero/about.php?about=about . Accessed June 23, 2017
  • 26 Manager R. (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014
  • 27 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 . Available at: http://handbook-5-1.cochrane.org/ . Accessed June 23, 2017
  • 28 Shea BJ, Grimshaw JM, Wells GA. , et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7: 10
  • 29 Wu SF, Lin HY, Huang FK. , et al. Efficacy of medical treatment for infantile hypertrophic pyloric stenosis: a meta-analysis. Pediatr Neonatol 2016; 57 (06) 515-521
  • 30 Aspelund G, Langer JC. Current management of hypertrophic pyloric stenosis. Semin Pediatr Surg 2007; 16 (01) 27-33
  • 31 Schwartz MZ. Hypertrophic pyloric stenosis. In: Grosfeld JL, O'Neill JA. , eds. Pediatric Surgery. Chicago, IL: Mosby; 2006: 1215-1224
  • 32 Kawahara H, Imura K, Yagi M, Kubota A, Okada A. Motor abnormality in the gastroduodenal junction in patients with infantile hypertrophic pyloric stenosis. J Pediatr Surg 2001; 36 (11) 1641-1645
  • 33 Brown JH, Laiken N. Muscarinic receptor agonists and antagonists. In: Laurence L, . Brunton, Bruce A, . Chabner, Björn C. . Knollmann, eds. Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill Education/Medical; 2011: 219-238
  • 34 Jones P, Dauger S, Denjoy I. , et al. The effect of atropine on rhythm and conduction disturbances during 322 critical care intubations. Pediatr Crit Care Med 2013; 14 (06) e289-e297
  • 35 Jones P, Dauger S, Peters MJ. Bradycardia during critical care intubation: mechanisms, significance and atropine. Arch Dis Child 2012; 97 (02) 139-144
  • 36 Mercer AE, Phillips R. Question 2: can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical pyloromyotomy?. Arch Dis Child 2013; 98 (06) 474-477